Suxia Luo

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

Jinwan Wang, Yan Sun, Qitao Yu et al. · PubMed · 2005 · 147 citations

Medicine, Oncology, Pharmacology +13

miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer

Qiang Fu, Jing Cheng, Jindai Zhang et al. · Oncology Reports · 2016 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis

Zhandong Zhang, Wei Yang, Ning Li et al. · Carcinogenesis · 2020 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +17

A negative feedback loop between miR‐200b and the nuclear factor‐κB pathway via <scp>IKBKB</scp>/<scp>IKK</scp>‐β in breast cancer cells

Hewen Wu, Guohui Wang, Zhengwei Wang et al. · FEBS Journal · 2015 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p

Xiaoqian Mu, Hongbo Wu, Jie Liu et al. · Biomedicine & Pharmacotherapy · 2020 · 41 citations · Full text

Life Sciences, Cancer Biology, Oncology +17